Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ketorolac thermosensitive formulation - Surge Therapeutics

Next Previous
Drug Profile

Ketorolac thermosensitive formulation - Surge Therapeutics

Alternative Names: SRG-514

Latest Information Update: 19 Feb 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Surge Therapeutics
  • Class 2 ring heterocyclic compounds; Antineoplastics; Azabicyclo compounds; Benzene derivatives; Carboxylic acids; Immunotherapies; Ketones; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrroles; Small molecules
  • Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Breast cancer

Most Recent Events

  • 19 Feb 2026 Chemical structure information added.
  • 12 Feb 2026 Surge Therapeutics plans a registrational trial for Triple-negative-breast-cancer in 2026 (Parenteral)
  • 04 Jun 2024 Phase-I clinical trials in Breast cancer (Prevention) in USA (Parenteral) (NCT06300411)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top